Topics: Research and Development, ALS, Rare Diseases, GoBoldly
From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.
Catalyst-Logo-Featured-Image-Catalyst.
Yesterday at The Atlantic Festival, I had the chance to speak with Amy, a biopharmaceutical researcher focused on amyotrophic lateral sclerosis (ALS). As a young girl, Amy’s father inspired her to become a scientist. Years later, his ALS diagnosis made her life’s work personal.
Watch our conversation about the challenges of finding an ALS treatment and the hope we have in research and development. As our payment system evolves, it’s crucial that innovative medicines are accessible and affordable for the patients who need them.
Topics: Research and Development, ALS, Rare Diseases, GoBoldly
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."